Recombinant Human Apo-SAA1 protein CD02307 from Bioassay Technology Laboratory

Description

Serum amyloid A proteins (SAA) represents a family of apolipoproteins that circulates in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 µg/ml in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid non-glycosylated polypeptide, which contains an 18 amino acid N-terminal sequence. Recombinant human apo-SAA1 is an 11.7 kDa protein containing 104 amino acid residues

Product Specs
ItemRecombinant Human Apo-SAA1 protein
CompanyBioassay Technology Laboratory
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberCD02307
Quantity10 ug
Molecular WeightApproximately 11.7 kDa, a single non-glycosylated polypeptide chain containing 104 amino acids
HostEscherichia coli
FormatLyophilized from a 0.2 µm filtered concentrated solution in 20 mM Tris-HCl, pH 9.0, 150 mM NaCl
Research AreaOthers
Purity> 98 % by SDS-PAGE and HPLC analyses
ActivityFully biologically active when compared to standard. The biological activity determined by a chemoattract bioassay using human monocytes is in a concentration range of 10-100 ng/ml
NCBI Full Gene Nameserum amyloid A1
NCBI Gene AliasesPIG4, SAA, SAA2, TP53I4